Align Technology (Align Technology) ROCE % : 15.13% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Align Technology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Align Technology's annualized ROCE % for the quarter that ended in Mar. 2024 was 15.13%.

Align Technology ROCE % Historical Data

The historical data trend for Align Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Align Technology ROCE % Chart

Align Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

35.60

15.38

25.96

16.27

16.34

Align Technology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															13.49	17.34	16.16	18.01	15.13

Align Technology ROCE % Calculation

Align Technology's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	656.654	/	( ( (5947.947 - 1925.887)	+	(6083.877 - 2066.611) )	/ 2 )
	=	656.654	/	( (4022.06	+	4017.266)	/ 2 )
	=	656.654	/	4019.663
	=	16.34 %

Align Technology's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	616.54	/	( ( (6083.877 - 2066.611)	+	(6155.754 - 2023.041) )	/ 2 )
	=	616.54	/	( ( 4017.266	+	4132.713 )	/ 2 )
	=	616.54	/	4074.9895
	=	15.13 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Align Technology (NAS:ALGN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Align Technology ROCE % Related Terms

Thank you for viewing the detailed overview of Align Technology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Align Technology (Align Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (NAS:ALGN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ALGN:Mexico AFW:Germany AFW:Germany A1LG34:Brazil

Address

410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85281

Website

https://www.aligntech.com

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.

Executives

Joseph M Hogan	director, officer: President and CEO	C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Kevin J Dallas	director	C/O ALIGN TECHNOLOGY INC., 2560 ORCHARD PARKWAY, SAN JOSE CA 95134
John Morici	officer: Chief Financial Officer	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Anne Myong	director	2820 ORCHARD PARKWAY, SAN JOSE CA 95141
Warren S Thaler	director	C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Larkin C Raymond Jr	director	C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105
Julie Ann Coletti	officer: SVP, Chief Legal & Regulatory	2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Greg J Santora	director	4201 GRANT COURT, PLEASANTON CA 94566
Stuart A Hockridge	officer: VP, Global Human Resources	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Emory Wright	officer: VP, Operations	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
George J Morrow	director	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Andrea Lynn Saia	director	C/O COCA-COLA ENTERPRISES, INC., 2500 WINDY RIDGE PARKWAY, NW, 14TH FLOOR, ATLANTA GA 30339
Thomas M Prescott	director	C/O ALIGN TECHNOLOGY INC, 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Yuval Shaked	officer: SVP and Mgng Director, Itero	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Jennifer Olson	officer: VP& Mng Dir. D-DCC	C/O ALIGN TECHNOLOGY, INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131